Clinical Trials Q4 2023
Protected: Tackling common disease burden through clinical trial innovation
There is no excerpt because this is a protected post.
Clinical Trials Q2 2022
Public involvement in research leads to a better experience for all
Clinical research shouldn’t just be shaped by the researchers conducting it – the voices of patients, carers and other members of the public are vital. A variety of voices involved in clinical research makes the clinical trial experience a better one for all, with richer results, drawing on patients’ experience and knowledge of what is … Continued
Improving outcomes for neurology clinical trials
Clinical trials in neurological diseases are a complex area of research where figures suggest there is an unusually high failure rate. Data from the United States shows that only 5.9% of phase I neurology clinical trial drugs are likely to get FDA approval and of the 2,352 neurology clinical trials started in 2020, fewer than … Continued